Dr. Ben Synth explores what clinical trials and real-world data reveal about stopping Ozempic and similar GLP-1 medications. From understanding why most patients regain significant weight to the biological mechanisms driving rebound effects, this series examines the science behind discontinuation and whether these drugs require lifelong use. For more content like this, visit QuietPlease.ai This show includes AI-generated content.
Copyright 2025 Inception Point Ai
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.